Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$1B |
| 2 |
Netflix
NFLX
|
+$721M |
| 3 |
Apple
AAPL
|
+$468M |
| 4 |
UnitedHealth
UNH
|
+$422M |
| 5 |
GE Vernova
GEV
|
+$376M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$673M |
| 2 |
Robinhood
HOOD
|
+$481M |
| 3 |
Meta Platforms (Facebook)
META
|
+$433M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$402M |
| 5 |
Palantir
PLTR
|
+$380M |
Sector Composition
| 1 | Technology | 19.67% |
| 2 | Healthcare | 15.34% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.51% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1026
RCM Technologies
RCMT
$200M
| $10.7M | 0.01% |
452,673
-6,800
| -1% | -$160K |
|
1027
Center Bancorp
CNOB
$1.27B
| $10.6M | 0.01% |
459,746
+278,559
| +154% | +$6.45M |
|
1028
BridgeBio Pharma
BBIO
$10.1B
| $10.6M | 0.01% |
+245,946
| New | +$10.6M |
|
1029
Stanley Black & Decker
SWK
$12.3B
| $10.6M | 0.01% |
156,362
-331,400
| -68% | -$22.5M |
|
1030
TriCo Bancshares
TCBK
$1.49B
| $10.5M | 0.01% |
260,517
+38,174
| +17% | +$1.55M |
|
1031
AngioDynamics
ANGO
$446M
| $10.5M | 0.01% |
1,062,729
+166,800
| +19% | +$1.65M |
|
|
SII
1032
Sprott
SII
$1.79B
| $10.5M | 0.01% |
152,500
+33,400
| +28% | +$2.31M |
|
1033
KBR
KBR
$6.39B
| $10.5M | 0.01% |
219,700
+208,000
| +1,778% | +$9.97M |
|
1034
Zillow
ZG
$20.8B
| $10.5M | 0.01% |
153,600
+26,500
| +21% | +$1.81M |
|
1035
Innodata
INOD
$1.94B
| $10.5M | 0.01% |
204,690
-387,100
| -65% | -$19.8M |
|
1036
Harmony Gold Mining
HMY
$9.53B
| $10.5M | 0.01% |
750,447
-317,673
| -30% | -$4.44M |
|
1037
Assured Guaranty
AGO
$3.96B
| $10.5M | 0.01% |
120,000
+113,000
| +1,614% | +$9.84M |
|
|
GAP
1038
The Gap, Inc.
GAP
$9B
| $10.4M | 0.01% |
+478,700
| New | +$10.4M |
|
|
BRKL
1039
DELISTED
Brookline Bancorp
BRKL
| $10.4M | 0.01% |
989,013
-61,300
| -6% | -$647K |
|
1040
Costamare
CMRE
$1.47B
| $10.4M | 0.01% |
1,145,232
+23,000
| +2% | +$210K |
|
|
LTM
1041
LATAM Airlines Group S.A. American Depositary Shares (each representing two thousand (2,000) shares of Common Stock)
LTM
$14.7B
| $10.4M | 0.01% |
254,900
+84,900
| +50% | +$3.45M |
|
1042
Scholar Rock
SRRK
$3.07B
| $10.3M | 0.01% |
291,200
-26,200
| -8% | -$928K |
|
1043
Rayonier Advanced Materials
RYAM
$411M
| $10.2M | 0.01% |
2,658,046
+608,594
| +30% | +$2.34M |
|
1044
Consumers Staples Select Sector SPDR Fund
XLP
$16.1B
| $10.2M | 0.01% |
+126,200
| New | +$10.2M |
|
1045
Primerica
PRI
$8.9B
| $10.2M | 0.01% |
37,300
-25,700
| -41% | -$7.03M |
|
|
UHT
1046
Universal Health Realty Income Trust
UHT
$584M
| $10.2M | 0.01% |
255,010
+400
| +0.2% | +$16K |
|
1047
Dimensional Short-Duration Fixed Income ETF
DFSD
$5.18B
| $10.2M | 0.01% |
212,121
-153,779
| -42% | -$7.38M |
|
1048
1st Source
SRCE
$1.58B
| $10.2M | 0.01% |
163,914
-700
| -0.4% | -$43.4K |
|
1049
Reliance Steel & Aluminium
RS
$15.6B
| $10.2M | 0.01% |
+32,412
| New | +$10.2M |
|
|
SAGE
1050
DELISTED
Sage Therapeutics
SAGE
| $10.2M | 0.01% |
1,113,400
+343,700
| +45% | +$3.13M |
|